Bracket, the clinical trial technology and specialty services provider with offices in Wayne, has been acquired by private equity firm Genstar Capital, writes John George for the Philadelphia Business Journal.

San Francisco’s Genstar Capital purchased Bracket from Parthenon Capital Partners, which has owned the company for the last four years. The company has more than 700 employees, almost 175 of which work in its Wayne office, and delivers services to drug developers in more than 90 countries.

“What this means for us, we have a new financial partner, Genstar, that has a lot of experience in the clinical research industry and is very well respected in the industry,” said Jeff Kinell, CEO of Bracket. “They will be able to provide capital to grow our business here in in Philadelphia and at our other locations.”

Bracket specializes in developing technology that helps pharmaceutical and biotechnology companies maximize clinical data integrity. This, in turn, helps improve the outcome of clinical trials.

“Our technologies are used by our customers to improve the quality of the clinical data that they obtain during the research studies by moving from a paper-based system to an automated system,” said Kinell.

Read more about Bracket’s new owner in the Philadelphia Business Journal by clicking here.